BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33092526)

  • 21. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.
    Kumar S; Warrell J; Li S; McGillivray PD; Meyerson W; Salichos L; Harmanci A; Martinez-Fundichely A; Chan CWY; Nielsen MM; Lochovsky L; Zhang Y; Li X; Lou S; Pedersen JS; Herrmann C; Getz G; Khurana E; Gerstein MB
    Cell; 2020 Mar; 180(5):915-927.e16. PubMed ID: 32084333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin accessibility prediction via a hybrid deep convolutional neural network.
    Liu Q; Xia F; Yin Q; Jiang R
    Bioinformatics; 2018 Mar; 34(5):732-738. PubMed ID: 29069282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures.
    Lee J; Lee AJ; Lee JK; Park J; Kwon Y; Park S; Chun H; Ju YS; Hong D
    Nucleic Acids Res; 2018 Jul; 46(W1):W102-W108. PubMed ID: 29790943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A user guide for the online exploration and visualization of PCAWG data.
    Goldman MJ; Zhang J; Fonseca NA; Cortés-Ciriano I; Xiang Q; Craft B; Piñeiro-Yáñez E; O'Connor BD; Bazant W; Barrera E; Muñoz-Pomer A; Petryszak R; Füllgrabe A; Al-Shahrour F; Keays M; Haussler D; Weinstein JN; Huber W; Valencia A; Park PJ; Papatheodorou I; Zhu J; Ferretti V; Vazquez M
    Nat Commun; 2020 Jul; 11(1):3400. PubMed ID: 32636365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CNCDatabase: a database of non-coding cancer drivers.
    Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
    Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
    Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
    Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes.
    Przytycki PF; Singh M
    Genome Med; 2017 Aug; 9(1):79. PubMed ID: 28841835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
    Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
    Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. isma: an R package for the integrative analysis of mutations detected by multiple pipelines.
    Di Nanni N; Moscatelli M; Gnocchi M; Milanesi L; Mosca E
    BMC Bioinformatics; 2019 Feb; 20(1):107. PubMed ID: 30819096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional annotation of noncoding mutations in cancer.
    Umer HM; Smolinska K; Komorowski J; Wadelius C
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34282050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
    Chalmers ZR; Connelly CF; Fabrizio D; Gay L; Ali SM; Ennis R; Schrock A; Campbell B; Shlien A; Chmielecki J; Huang F; He Y; Sun J; Tabori U; Kennedy M; Lieber DS; Roels S; White J; Otto GA; Ross JS; Garraway L; Miller VA; Stephens PJ; Frampton GM
    Genome Med; 2017 Apr; 9(1):34. PubMed ID: 28420421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathway and network analysis of more than 2500 whole cancer genomes.
    Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
    Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide analysis of noncoding regulatory mutations in cancer.
    Weinhold N; Jacobsen A; Schultz N; Sander C; Lee W
    Nat Genet; 2014 Nov; 46(11):1160-5. PubMed ID: 25261935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.
    Guo YA; Chang MM; Huang W; Ooi WF; Xing M; Tan P; Skanderup AJ
    Nat Commun; 2018 Apr; 9(1):1520. PubMed ID: 29670109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OncoCis: annotation of cis-regulatory mutations in cancer.
    Perera D; Chacon D; Thoms JA; Poulos RC; Shlien A; Beck D; Campbell PJ; Pimanda JE; Wong JW
    Genome Biol; 2014; 15(10):485. PubMed ID: 25298093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model selection and robust inference of mutational signatures using Negative Binomial non-negative matrix factorization.
    Pelizzola M; Laursen R; Hobolth A
    BMC Bioinformatics; 2023 May; 24(1):187. PubMed ID: 37158829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CScape: a tool for predicting oncogenic single-point mutations in the cancer genome.
    Rogers MF; Shihab HA; Gaunt TR; Campbell C
    Sci Rep; 2017 Sep; 7(1):11597. PubMed ID: 28912487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers.
    Elliott K; Boström M; Filges S; Lindberg M; Van den Eynden J; Ståhlberg A; Clausen AR; Larsson E
    PLoS Genet; 2018 Dec; 14(12):e1007849. PubMed ID: 30586386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.